Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05085340Completed

MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention

Role: collaborator

NCT03915366Phase 2Completed

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Role: collaborator

NCT04568967Not ApplicableCompleted

TB-CAPT EXULTANT - HIV

Role: collaborator

NCT04568954Not ApplicableCompleted

TB-CAPT CORE Truenat Trial

Role: collaborator

NCT03671109Phase 3Completed

Improving Maternal heAlth by Reducing Malaria in African HIV Women

Role: collaborator

NCT05303168Completed

Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations

Role: collaborator

NCT04422015Completed

Biological Mechanisms in Afebrile P. Falciparum Malaria

Role: collaborator

All 7 trials loaded